Generation Bio Co
NASDAQ:GBIO
Generation Bio Co
NASDAQ:GBIO
Price:
5.34
USD
Market Closed
Market Cap:
$36m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Generation Bio Co
NASDAQ:GBIO
|
US |
|
A
|
Azitra Inc
AMEX:AZTR
|
US |
|
O
|
Onoff AG
XETRA:2QU
|
DE |
|
O
|
Orient Group Inc
SSE:600811
|
CN |
|
V
|
Veidekke ASA
OSE:VEI
|
NO |
|
V
|
Valmet Oyj
LSE:0QIW
|
FI |
|
First Industrial Realty Trust Inc
NYSE:FR
|
US |
|
Shenzhen InfoGem Technologies Co Ltd
SZSE:300085
|
CN |
|
B
|
Banco BTG Pactual SA
BOVESPA:BPAC3
|
BR |
|
Kinden Corp
TSE:1944
|
JP |
|
P
|
Priya Ltd
BSE:524580
|
IN |
Multiples-Based Value
The
Multiples-Based Value for
Generation Bio Co (GBIO)
under the Base Case is
hidden
USD.
Compared with the current market price of 5.34 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GBIO Multiples-Based Value
LOCKED
Multiples Across Competitors
GBIO Competitors Multiples
Generation Bio Co Competitors
Generation Bio Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Generation Bio Co
NASDAQ:GBIO
|
36m USD | 2.4 | -0.6 | 0.6 | 0.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.5 | 42.8 | 43.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
